Bechelli 1985.

Methods	Allocation: randomised, stratified by Schizophrenia subgroups. Blindness: double. Duration: 6 months (preceded by 7 day washout).
Participants	Diagnosis: schizophrenia (RDC). History: >2 episodes, stabilized for 3 months, duration ill ‐ mean 12 yrs (HD) 9 yrs (PP), informed consent given. N = 41. Age: 19‐50 yrs (mean range 30‐33 yrs). Sex: all male. Race: caucasian. Setting: out‐patient clinic.
Interventions	1. Haloperidol decanoate: dose mean 100mg/injection, monthly, range 50‐100mg/injection. N=21. 2. Pipothiazine palmitate: dose mean 75 (**65)mg/ injection, monthly, range 50‐ 125mg/injection. N=20.
Outcomes	Mental state (BPRS). Leaving the study early. Additional medication. Side effects (Bordeleau Scale/AIMS). Unable to use ‐ Global Impression (CGI ‐ no data). Weight measures (non‐clinical outcomes, data not usuable).
Notes	* Spitzer 1997 ** The mean dose of PP is given as 75mg in the abstract and 65mg in the paper.
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Unclear risk	B ‐ Unclear